Bryce Point Capital, LLC Viatris Inc Transaction History
Bryce Point Capital, LLC
- $345 Billion
- Q4 2024
A detailed history of Bryce Point Capital, LLC transactions in Viatris Inc stock. As of the latest transaction made, Bryce Point Capital, LLC holds 40,555 shares of VTRS stock, worth $429,883. This represents 0.15% of its overall portfolio holdings.
Number of Shares
40,555Holding current value
$429,883% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding VTRS
# of Institutions
1,117Shares Held
973MCall Options Held
2.69MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA142MShares$1.51 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$982 Million0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$669 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$663 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$517 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.9B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...